These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 635510

  • 1. [Treatment with high-dose beta-pyridylcarbinol: results in patients with hypercholesterinemia].
    Mordasini R, Schlumpf E, Nobile PC, Brun del Re G, Riva G.
    Schweiz Med Wochenschr; 1978 Apr 08; 108(14):533-8. PubMed ID: 635510
    [Abstract] [Full Text] [Related]

  • 2. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
    Mordasini R, Müller A, Klose G, Middelhoff G, Augustin J, Haase W, Greten H.
    MMW Munch Med Wochenschr; 1978 Apr 14; 120(15):525-8. PubMed ID: 206826
    [Abstract] [Full Text] [Related]

  • 3. [Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia].
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1983 Apr 14; 33(12):1682-4. PubMed ID: 6686774
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of hypercholesterolemia with beta-pyridylcarbinol. Experiences after long term treatment over 8 years (author's transl)].
    Zöllner N, Keller C, Wolfram G.
    Med Klin; 1976 Apr 30; 71(18):768-74. PubMed ID: 818496
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of hyperlipidaemia. A comparison of the efficacy of clofibrate and beta-pyridylcarbinol (author's transl)].
    Wolfram G, Keller C, Kilani S, Zöllner N.
    Dtsch Med Wochenschr; 1976 Jan 16; 101(3):76-81. PubMed ID: 1245160
    [Abstract] [Full Text] [Related]

  • 6. [Drug treatment of hypercholesterolemia. Experience with a combination of dextrothyroxine and betapyridylcarbinol (author's transel)].
    Schneider J, Schubotz R, Manteuffel Ev, Kaffarnik H.
    Med Klin; 1978 Jun 09; 73(23):874-7. PubMed ID: 661731
    [Abstract] [Full Text] [Related]

  • 7. [Procetophen--an alternative in the treatment of hypercholsterinemia?].
    Mordasini R, Grandjean EM, Nobile PC, Paumgartner G, Riva G.
    Schweiz Med Wochenschr; 1979 Aug 18; 109(31):1140-3. PubMed ID: 472702
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of beta-pyridylcarbinol on lipoprotein lipids in primary type IIa hyperlipoproteinemia.
    Schwandt P, Weisweiler P, Neureuther G.
    Atherosclerosis; 1979 Sep 18; 34(1):35-9. PubMed ID: 227427
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
    Lukacsko P, Walters EJ, Cullen EI, Niecestro R, Friedhoff LT.
    Curr Med Res Opin; 2004 Jan 18; 20(1):13-8. PubMed ID: 14741066
    [Abstract] [Full Text] [Related]

  • 15. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
    März W, Grützmacher P, Paul D, Siekmeier R, Schoeppe W, Gross W.
    Int J Clin Pharmacol Ther; 1994 Feb 18; 32(2):92-7. PubMed ID: 8004365
    [Abstract] [Full Text] [Related]

  • 16. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
    Arntz HR, Klemens UH, Vollmar LJ, Lang PD.
    Med Klin; 1978 Dec 08; 73(49):1731-7. PubMed ID: 723760
    [Abstract] [Full Text] [Related]

  • 17. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
    Castaño G, Mas R, Fernández L, Illnait J, Gámez R, Alvarez E.
    Int J Clin Pharmacol Res; 2001 Dec 08; 21(1):43-57. PubMed ID: 11708574
    [Abstract] [Full Text] [Related]

  • 18. [Therapy of primary hyperlipoproteinemia types IIa, IIb and IV using beta pyridylcarbinol Study on three phases under ambulatory conditions].
    Klemens UH, von Löwis P.
    Dtsch Med Wochenschr; 1973 Jun 15; 98(24):1197-202. PubMed ID: 4350685
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.